ES2074191T3 - Oxazolidinonas. - Google Patents

Oxazolidinonas.

Info

Publication number
ES2074191T3
ES2074191T3 ES91108081T ES91108081T ES2074191T3 ES 2074191 T3 ES2074191 T3 ES 2074191T3 ES 91108081 T ES91108081 T ES 91108081T ES 91108081 T ES91108081 T ES 91108081T ES 2074191 T3 ES2074191 T3 ES 2074191T3
Authority
ES
Spain
Prior art keywords
oxazolidinones
composent
substitutes
radicals
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91108081T
Other languages
English (en)
Inventor
Helmut Prucher
Henning Dr Bottcher
Christoph Dr Seyfried
Anton Dr Haase
Klaus-Otto Dr Minck
Rudolf Dr Gottschlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2074191T3 publication Critical patent/ES2074191T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA OXAZOLIDINONA DE FORMULA (I) Y SUS SALES Y DESCRIBE LA APLICACION DE (I) COMO COMPONENTE ACTIVO AMORTIGUADOR DEL SISTEMA NERVIOSO. LOS RADICALES Y SUSTITUYENTES TIENEN UN SIGNIFICADO DESCRITO EN LA PATENTE.
ES91108081T 1990-05-29 1991-05-18 Oxazolidinonas. Expired - Lifetime ES2074191T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4017211A DE4017211A1 (de) 1990-05-29 1990-05-29 Oxazolidinone

Publications (1)

Publication Number Publication Date
ES2074191T3 true ES2074191T3 (es) 1995-09-01

Family

ID=6407378

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91108081T Expired - Lifetime ES2074191T3 (es) 1990-05-29 1991-05-18 Oxazolidinonas.

Country Status (16)

Country Link
US (1) US5232931A (es)
EP (1) EP0459256B1 (es)
JP (1) JPH06340661A (es)
KR (1) KR910020006A (es)
AT (1) ATE124943T1 (es)
AU (1) AU640783B2 (es)
CA (1) CA2043317A1 (es)
DE (2) DE4017211A1 (es)
DK (1) DK0459256T3 (es)
ES (1) ES2074191T3 (es)
HU (1) HUT61016A (es)
IE (1) IE68665B1 (es)
MX (1) MX9203243A (es)
PT (1) PT97773B (es)
TW (1) TW222000B (es)
ZA (1) ZA914095B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL174222B1 (pl) * 1993-01-27 1998-06-30 Inst Farmaceutyczny Środek farmaceutyczny działający na ośrodkowy układ nerwowy
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DE4405378A1 (de) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DK0710657T3 (da) 1994-11-02 1999-05-25 Merck Patent Gmbh Adhæsionsreceptor-antagonister
DE4439846A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
DE19531321A1 (de) * 1995-08-25 1997-02-27 Merck Patent Gmbh Piperidinylmethyloxazolidinone
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
DE10050236A1 (de) * 2000-10-11 2002-04-25 Merck Patent Gmbh Verwendung bestimmter Substanzen, die an den Sigma-Rezeptor binden, zur Behandlung von Sarkomen und Karzinomen
CA2673654A1 (en) * 2007-01-10 2008-07-17 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
US8273770B2 (en) * 2007-07-21 2012-09-25 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
WO2021236879A1 (en) 2020-05-20 2021-11-25 The Board Of Trustees Of The University Of Illinois Method for treating lysosomal storage diseases with histatin peptides
CN115925694A (zh) * 2022-10-19 2023-04-07 成都海博为药业有限公司 一种pak4激酶抑制剂及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060816C3 (de) 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
EP0006524A1 (de) * 1978-06-22 1980-01-09 Ciba-Geigy Ag Neue Tetrahydropyridin- und Piperidinderivate und deren Säureadditionssalze, Verfahren zu deren Herstellung und solche enthaltende pharmazeutische Zusammensetzungen
DE2852945A1 (de) * 1978-12-07 1980-06-26 Boehringer Sohn Ingelheim Benzodioxanyl-hydroxyaethylpiperidyl- imidazolidinone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
GB8726763D0 (en) * 1987-11-16 1987-12-23 Fujisawa Pharmaceutical Co Thiazole compounds

Also Published As

Publication number Publication date
TW222000B (es) 1994-04-01
AU7736191A (en) 1991-12-05
IE911817A1 (en) 1991-12-04
HU911797D0 (en) 1991-12-30
EP0459256A1 (de) 1991-12-04
AU640783B2 (en) 1993-09-02
PT97773A (pt) 1992-03-31
US5232931A (en) 1993-08-03
DE4017211A1 (de) 1991-12-05
DK0459256T3 (da) 1995-08-21
JPH06340661A (ja) 1994-12-13
KR910020006A (ko) 1991-12-19
ATE124943T1 (de) 1995-07-15
IE68665B1 (en) 1996-07-10
DE59105960D1 (de) 1995-08-17
HUT61016A (en) 1992-11-30
PT97773B (pt) 1998-10-30
CA2043317A1 (en) 1991-11-30
MX9203243A (es) 1992-07-01
EP0459256B1 (de) 1995-07-12
ZA914095B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
ES2074191T3 (es) Oxazolidinonas.
PE20160548A1 (es) Sulfonamidas como moduladores de canales de sodio
DK0759295T3 (da) Anvendelse af adamantan-derivater til behandling af tinnitus
PE20020858A1 (es) Indanil aminas aciladas
DK0777659T3 (da) Morpholinderivater og deres anvendelse som terapeutiske midler
AR032436A1 (es) Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro
AR030432A1 (es) Uso de derivados de quinazolina en la preparacion de un medicamento para ser usado en la inhibicion de la quinasa aurora2, compuestos relacionados, y composicion farmaceutica.
ECSP066312A (es) Derivados piridilo y su uso como agentes terapéuticos
UY27357A1 (es) Nuevos agentes antidiabéticos .
BRPI0413059A (pt) derivados de piridila e seu uso como agentes terapêuticos
ATE283268T1 (de) 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission
DE60317208D1 (de) Pleuromutilinderivate als antimikrobielle mittel
PT892794E (pt) Prodrogas de n-hidroximetil-talidomida aciladas de efeito imunomodulador
TR200400526T4 (tr) Göz kurumasının tedavisi için lipoksin A4 ve analogları
ECSP23095485A (es) N-(hidroxialquil (hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio
AR016108A1 (es) Un derivado de bencimidazol y una composicion farmaceutica que lo contiene.
ES2079469T3 (es) (pirrolidin-2-ona-l-il) acetamidas como mejoradores de aprendimiento y memoria y composiciones farmaceuticas que las comprenden.
ES2171553T3 (es) Derivados de quinoxalina utiles en terapia.
NO169229C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-(3-alkyl-5-tert.butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner
UY26846A1 (es) Derivados de la pirrolidina
ES2058203T3 (es) Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos.
ITMI920979A1 (it) N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
ATE490768T1 (de) Zytokin-modulatoren unter verwendung von zyklischen glyceriden von essentiellen mehrfach ungesättigten fettsäuren
UY27448A1 (es) Ésteres de análogos de 3-desoxi-vitamina d3
AR028667A1 (es) Derivados de higromicina a

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 459256

Country of ref document: ES